Dr. Valerie Montgomery Rice, President and CEO of Morehouse School of Medicine, has been awarded the 2025 Healthcare Champions Lifetime Achievement Award by the Atlanta Business Chronicle, recognizing her exceptional contributions to healthcare and unwavering commitment to health equity.
As the first woman to lead Morehouse School of Medicine, Montgomery Rice has been a pivotal figure in enhancing medical education and research focused on diseases that disproportionately affect marginalized communities. Her impact extends beyond the United States, influencing health outcomes in developing and emerging countries.
Montgomery Rice currently serves as a Special Advisor to GeoVax Labs' Chairman, CEO, and Board of Directors, bringing her strategic healthcare insights to the biotechnology company's mission of developing innovative vaccines and immunotherapies for underserved populations.
The award highlights Montgomery Rice's significant work in addressing systemic healthcare disparities. Her contributions include advancing research on diseases that predominantly impact minority communities and promoting accessible healthcare solutions globally.
GeoVax's product pipeline, which includes a next-generation COVID-19 vaccine for immunocompromised individuals and innovative immunotherapies, aligns closely with Montgomery Rice's vision of equitable healthcare access.
The formal recognition will take place at the Atlanta Business Chronicle's Healthcare Champion Awards ceremony on March 20, 2025, celebrating her remarkable achievements in transforming healthcare delivery and research.
